GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » Price-to-Owner-Earnings

ABL Diagnostics (XPAR:ABLD) Price-to-Owner-Earnings : 50.67 (As of Jun. 01, 2024)


View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics Price-to-Owner-Earnings?

As of today (2024-06-01), ABL Diagnostics's share price is €3.04. ABL Diagnostics's Owner Earnings per Share (TTM) ended in Dec. 2022 was €0.06. It's Price-to-Owner-Earnings for today is 50.67.


The historical rank and industry rank for ABL Diagnostics's Price-to-Owner-Earnings or its related term are showing as below:

XPAR:ABLD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.72   Med: 50.48   Max: 229.4
Current: 48.25

During the past 13 years, the highest Price-to-Owner-Earnings of ABL Diagnostics was 229.40. The lowest was 5.72. And the median was 50.48.


XPAR:ABLD's Price-to-Owner-Earnings is ranked worse than
80.3% of 269 companies
in the Healthcare Providers & Services industry
Industry Median: 20.21 vs XPAR:ABLD: 48.25

As of today (2024-06-01), ABL Diagnostics's share price is €3.04. ABL Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €0.05. Therefore, ABL Diagnostics's PE Ratio for today is 64.68.

As of today (2024-06-01), ABL Diagnostics's share price is €3.04. ABL Diagnostics's EPS without NRI for the trailing twelve months (TTM) ended in was €0.05. Therefore, ABL Diagnostics's PE Ratio without NRI for today is 64.68.

During the past 13 years, ABL Diagnostics's highest PE Ratio without NRI was 699.13. The lowest was 23.95. And the median was 106.52.


ABL Diagnostics Price-to-Owner-Earnings Historical Data

The historical data trend for ABL Diagnostics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics Price-to-Owner-Earnings Chart

ABL Diagnostics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 229.40

ABL Diagnostics Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 229.40 -

Competitive Comparison of ABL Diagnostics's Price-to-Owner-Earnings

For the Health Information Services subindustry, ABL Diagnostics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ABL Diagnostics's Price-to-Owner-Earnings Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where ABL Diagnostics's Price-to-Owner-Earnings falls into.



ABL Diagnostics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

ABL Diagnostics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=3.04/0.06
=50.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ABL Diagnostics  (XPAR:ABLD) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


ABL Diagnostics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Diagnostics (XPAR:ABLD) Business Description

Traded in Other Exchanges
N/A
Address
72c, rue de, WOIPPY, Thionville, FRA, 57140
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines